Volume 11 Issue 2
Mar.  2020
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2020  >  11(2): 304-310
Dai Qingqing, Zhao Hongchuan, Wang Guobin, et al. Progress on application of marginal donor liver and organ function maintenance in liver transplantation[J]. ORGAN TRANSPLANTATION, 2020, 11(2): 304-310. doi: 10.3969/j.issn.1674-7445.2020.02.020
Citation: Dai Qingqing, Zhao Hongchuan, Wang Guobin, et al. Progress on application of marginal donor liver and organ function maintenance in liver transplantation[J]. ORGAN TRANSPLANTATION, 2020, 11(2): 304-310. doi: 10.3969/j.issn.1674-7445.2020.02.020
shu

Progress on application of marginal donor liver and organ function maintenance in liver transplantation

doi: 10.3969/j.issn.1674-7445.2020.02.020

  • Organ Transplantation Center, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China

More Information
  • Corresponding author: Zhao Hongchuan, Email: zhc0117@sina.com
  • Received Date: 2019-12-23
    Available Online: 2021-01-19
  • Publish Date: 2020-03-15
    Abstract
  • Liver transplantation is the only effective method to treat various end-stage liver diseases. The shortage of standard donor liver is the main factor limiting the development of liver transplantation, whereas the application of marginal donor liver has significantly expanded the source of donor liver. New technologies, such as extracorporeal membrane oxygenation (ECMO), mechanical perfusion and hypothermia, can significantly improve the quality of marginal donor liver, which has good development prospects in organ function maintenance. This article reviews the common types of marginal donor liver and the application of related novel technologies in the maintenance of marginal donor liver function.

     

    • FullText(HTML)
  • loading
    • References(36)
  • [1]
    VODKIN I. Extended criteria donors in liver transplantation[J]. Clin Liver Dis, 2017, 21(2):289-301. DOI: 10.1016/j.cld.2016.12.004.
    [2]
    JIMÉNEZ-GALANES S, MENEU-DIAZ MJ, ELOLA-OLASO AM, et al. Liver transplantation using uncontrolled non-heart-beating donors under normothermic extracorporeal membrane oxygenation[J]. Liver Transpl, 2009, 15(9):1110-1118. DOI: 10.1002/lt.21867.
    [3]
    D'ERRICO A, RIEFOLO M, SERENARI M, et al. The histological assessment of liver fibrosis in grafts from extended criteria donors predicts the outcome after liver transplantation: a retrospective study[J]. Dig Liver Dis, 2020, 52(2):185-189. DOI: 10.1016/j.dld.2019.05.013.
    [4]
    NAIR A. Extended criteria donors in liver transplantation-from marginality to mainstream[J]. Hepatobiliary Surg Nutr, 2018, 7(5):386-388. DOI: 10.21037/hbsn.2018.06.08.
    [5]
    BADAWY A, KAIDO T, UEMOTO S. Current status of liver transplantation using marginal grafts[J]. J Invest Surg, 2018, 20:1-12. DOI: 10.1080/08941939.2018.1517197.
    [6]
    TRAPERO-MARUGÁN M, LITTLE EC, BERENGUER M. Stretching the boundaries for liver transplant in the 21st century[J]. Lancet Gastroenterol Hepatol, 2018, 3(11):803-811. DOI: 10.1016/S2468-1253(18)30213-9.
    [7]
    PARK PJ, YU YD, YOON YI, et al. Single-center experience using marginal liver grafts in Korea[J]. Transplant Proc, 2018, 50(4):1147-1152. DOI: 10.1016/j.transproceed.2018.01.040.
    [8]
    GHINOLFI D, MARTI J, DE SIMONE P, et al. Use of octogenarian donors for liver transplantation: a survival analysis[J]. Am J Transplant, 2014, 14(9):2062-2071. DOI: 10.1111/ajt.12843.
    [9]
    LAKE JR, SHORR JS, STEFFEN BJ, et al. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis[J]. Am J Transplant, 2005, 5(3):549-557. DOI: 10.1111/j.1600-6143.2005.00741.x.
    [10]
    KIM DY, MOON J, ISLAND ER, et al. Liver transplantation using elderly donors: a risk factor analysis[J]. Clin Transplant, 2011, 25(2):270-276. DOI: 10.1111/j.1399-0012.2010.01222.x.
    [11]
    WU C, LU C, XU C. Short-term and long-term outcomes of liver transplantation using moderately and severely steatotic donor livers: a systematic review[J]. Medicine (Baltimore), 2018, 97(35):e12026. DOI: 10.1097/MD.0000000000012026.
    [12]
    POWNER DJ. Factors during donor care that may affect liver transplantation outcome[J]. Prog Transplant, 2004, 14(3):241-249. doi: 10.1177/152692480401400310
    [13]
    CYWINSKI JB, MASCHA E, MILLER C, et al. Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function[J]. Liver Transpl, 2008, 14(1):59-65. DOI: 10.1002/lt.21305.
    [14]
    AKOAD M, WAGENER M, FRANCIS F, et al. Outcome of imported liver allografts and impact on patient access to liver transplantation[J]. Transplant Proc, 2006, 38(10):3564-3566. DOI: 10.1016/j.transproceed.2006.10.037.
    [15]
    MATHUR AK, HEIMBACH J, STEFFICK DE, et al. Donation after cardiac death liver transplantation: predictors of outcome[J]. Am J Transplant, 2010, 10(11):2512-2519. DOI: 10.1111/j.1600-6143.2010.03293.x.
    [16]
    NGUYEN JH, BONATTI H, DICKSON RC, et al. Long-term outcomes of donation after cardiac death liver allografts from a single center[J]. Clin Transplant, 2009, 23(2):168-173. DOI: 10.1111/j.1399-0012.2009.00968.x.
    [17]
    CRISMALE JF, KHALID M, BHANSALI A, et al. Liver, simultaneous liver-kidney, and kidney transplantation from hepatitis C-positive donors in hepatitis C negative recipients: a single center study[J]. Clin Transplant, 2019:e13761. DOI: 10.1111/ctr.13761.
    [18]
    WEI L, CHEN D, ZHANG B, et al. Long-term outcome and recurrence of hepatitis B virus following liver transplantation from hepatitis B surface antigen-positive donors in a Chinese population[J]. J Viral Hepat, 2018, 25(12):1576-1581. DOI: 10.1111/jvh.12972.
    [19]
    WONG TC, FUNG JY, CUI TY, et al. Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis[J]. J Hepatol, 2019, 70(6):1114-1122. DOI: 10.1016/j.jhep.2019.03.003.
    [20]
    BAE SK, AKAMATSU N, TOGASHI J, et al. Hepatitis B virus recurrence after living donor liver transplantation of anti-HBc-positive grafts: a 22-year experience at a single center[J]. Biosci Trends, 2019, 13(5):448-455. DOI: 10.5582/bst.2019.01283.
    [21]
    LAI JC, O'LEARY JG, TROTTER JF, et al. Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study[J]. Liver Transpl, 2012, 18(5):532-538. DOI: 10.1002/lt.23396.
    [22]
    FENG S, BUELL JF, CHARI RS, et al. Tumors and transplantation: the 2003 third annual ASTS state-of-the-art winter symposium[J]. Am J Transplant, 2003, 3(12):1481-1487. doi: 10.1046/j.1600-6143.2003.00245.x
    [23]
    NALESNIK MA, WOODLE ES, DIMAIO JM, et al. Donor-transmitted malignancies in organ transplantation: assessment of clinical risk[J]. Am J Transplant, 2011, 11(6):1140-1147. DOI: 10.1111/j.1600-6143.2011.03565.x.
    [24]
    ASENI P, DE FEO TM, DE CARLIS L, et al. A prospective policy development to increase split-liver transplantation for 2 adult recipients: results of a 12-year multicenter collaborative study[J]. Ann Surg, 2014, 259(1):157-165. DOI: 10.1097.
    [25]
    VAGEFI PA, PAREKH J, ASCHER NL, et al. Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010[J]. Arch Surg, 2011, 146(9):1052-1059. DOI: 10.1001/archsurg.2011.218.
    [26]
    REDDY S, ZILVETTI M, BROCKMANN J, et al. Liver transplantation from non-heart-beating donors: current status and future prospects[J]. Liver Transpl, 2004, 10(10):1223-1232. DOI: 10.1002.
    [27]
    SAIDI RF. Utilization of expanded criteria donors in liver transplantation[J]. Int J Organ Transplant Med, 2013, 4(2):46-59. http://d.old.wanfangdata.com.cn/OAPaper/oai_doaj-articles_51eba3906b025a150d904fb7e2555d28
    [28]
    ASSALINO M, MAJNO P, TOSO C, et al. In situ liver splitting under extracorporeal membrane oxygenation in brain-dead donor[J]. Am J Transplant, 2018, 18(1):258-261. DOI: 10.1111/ajt.14461.
    [29]
    NASRALLA D, COUSSIOS CC, MERGENTAL H, et al. A randomized trial of normothermic preservation in liver transplantation[J]. Nature, 2018, 557(7703):50-56. DOI: 10.1038/s41586-018-0047-9.
    [30]
    BRUINSMA BG, YEH H, OZER S, et al. Subnormothermic machine perfusion for ex vivo preservation and recovery of the human liver for transplantation[J]. Am J Transplant, 2014, 14(6):1400-1409. DOI: 10.1111/ajt.12727.
    [31]
    SCHLEGEL A, MULLER X, KALISVAART M, et al. Outcomes of DCD liver transplantation using organs treated by hypothermic oxygenated perfusion before implantation[J]. J Hepatol, 2019, 70(1):50-57. DOI: 10.1016/j.jhep.2018.10.005.
    [32]
    GUARRERA JV, HENRY SD, SAMSTEIN B, et al. Hypothermic machine preservation facilitates successful transplantation of "orphan" extended criteria donor livers[J]. Am J Transplant, 2015, 15(1):161-169. DOI: 10.1111/ajt.12958.
    [33]
    MORITO N, OBARA H, MATSUNO N, et al. Regulated oxygenation of rewarming machine perfusion for porcine donation after cardiac death liver transplantation[J]. Transplant Proc, 2016, 48(4):1244-1246. DOI: 10.1016/j.transproceed.2015.12.098.
    [34]
    NIEMANN CU, FEINER J, SWAIN S, et al. Therapeutic hypothermia in deceased organ donors and kidney-graft function[J]. N Engl J Med, 2015, 373(5):405-414. DOI: 10.1056/NEJMoa1501969.
    [35]
    刘克普, 张更, 李智斌, 等.供体亚低温状态对公民逝世后器官捐献移植肾功能的影响[J].器官移植, 2017, 8(5):376-380.DOI: 10.3969/j.issn.1674-7445.2017.05.008.

    LIU KP, ZHANG G, LI ZB, et al. Effect of hypothermia status in donors on renal graft function after renal transplantation from donation after citizen's death[J]. Organ Transplant, 2017, 8(5): 376-380. DOI: 10.3969/j.issn.1674-7445.2017.05.008.
    [36]
    WRIGHT C, PATEL MS, GAO X, et al. The impact of therapeutic hypothermia used to treat anoxic brain injury after cardiopulmonary resuscitation on organ donation outcomes[J]. Ther Hypothermia Temp Manag, 2019, 9(4):258-264. DOI: 10.1089/ther.2018.0043.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (253) PDF downloads(20) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return